CE/CME

Child Trafficking and Exploitation: Screening, Intervention and Prevention

Welcome to the training on Child Trafficking and Exploitation: Screening, Intervention and Prevention provided by the Texas Health and Human Services Commission (HHSC) and the Texas Department of State Health Services (DSHS).

Credit Hours: 1.00 CE

Access denied

Please login or register to take this course.

Goal

The goal of this module is to equip Texas Health Steps providers and other pediatric health care professionals to recognize risk factors and signs of child trafficking and exploitation and to take appropriate steps to protect vulnerable children and adolescents.

Target Audience

Texas Health Steps providers and other interested health care professionals.

Specific Learning Objectives

  1. Assess risk factors and possible indicators of child trafficking and exploitation as part of routine clinical care.
  2. Formulate trauma-informed, culturally sensitive practices to identify and respond to children and adolescents who have experienced or are at risk for trafficking and exploitation.
  3. Determine appropriate referrals and resources that support and provide ongoing care to children and adolescents who have experienced trafficking and exploitation.

Notes on Nomenclature: This module focuses on sex and labor trafficking and exploitation of individuals under the age of 18 years. The terms “health care provider” and “provider” are used to denote clinicians who are educated, trained and licensed to deliver health care. In addition, the term “caregiver” refers to parents, legal guardians, family members and others who may be responsible for a child’s health care.

Please note this module expires on 6/30/2029.

This module was released on 6/30/2026.

Continuing Medical Education

The Texas Department of State Health Services Continuing Education Program is accredited by the Texas Medical Association to provide continuing medical education for physicians.

The Texas Department of State Health Services Continuing Education Program designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The Texas Department of State Health Services Continuing Education Program is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The Texas Department of State Health Services Continuing Education Program has designated a maximum of 1.00 contact hours of Nursing Continuing Professional Development.

Social Workers

The Texas Department of State Health Services Continuing Education Program has designated a maximum of 1.00 contact hours for Social Workers.

Certificate of Attendance

The Texas Department of State Health Services Continuing Education Program has designated a maximum of 1.00 hours for attendance.

Certified Community Health Worker

The Texas Department of State Health Services, Promotor(a)/Community Health Worker Training and Certification Program has certified this course for 1.00 contact hour(s) of continuing education for Certified Community Health Workers and Community Health Worker Instructors.

Successful completion of this continuing education activity includes:

  • Participating in 100% of the activity.
  • Successful completion of a post-test; must score 75% or higher.
  • Completion and submission of participant evaluation.

Commercial Support & Disclosure of Financial Relationships

This event received no commercial support.

The presenters and planning committee for this event have disclosed no financial relationships with ineligible companies.

Non-Endorsement Statement & Off Label Use

Accredited status does not imply endorsement of any commercial products or services by the Texas Department of State Health Services, Texas Medical Association, or American Nurses Credentialing Center.

The presenters did not disclose the use of products for a purpose other than what it had been approved for by the Food and Drug Administration.

Release Date: 6/30/2026

Termination Date: 6/30/2029